Cell Medica

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology (patents filed) enabling GMP compliant manufacture of antigen-specific T cells and employs a team of production specialists led by Rainer Knaus, PhD and Katy Newton, PhD. The in-house trial management team, led by Karen Hodgkin, has unique expertise in planning and executing cell therapy trials.